The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market reached US$ 3.57 Bn in 2022 (up by 4.7% over 2021). Outbreak of Covid-19 in the short-term, backed by “innovation” in the ...
Developers working on methicillin-resistant staphylococcus aureus (MRSA) treatments market are expected to invest resources into research and development activities, for the generation of new product ...
Ceftobiprole is a novel broad-spectrum cephalosporin antibiotic that has demonstrated significant efficacy in managing infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Its ...
MRSA (methicillin-resistant Staphylococcus aureus) is a well known superbug, a pathogenic microbe that can cause serious or fatal infections, which are resistant to treatment with standard antibiotics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback